Exact Mass: 452.3137724
Exact Mass Matches: 452.3137724
Found 450 metabolites which its exact mass value is equals to given mass value 452.3137724,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Repaglinide
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to cells of the pancreas to stimulate insulin release. Repaglinide induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naive to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sulfonylureas since their action is dependent on the presence of glucose. In addition to reducing postprandial and fasting blood glucose, meglitnides have been shown to decrease glycosylated hemoglobin (HbA1c) levels, which are reflective of the last 8-10 weeks of glucose control. Meglitinides appear to be more effective at lowering postprandial blood glucose than metformin, sulfonylureas and thiazolidinediones. Repaglinide is extensively metabolized in the liver and excreted in bile. Repaglinide metabolites do not possess appreciable hypoglycemic activity. Approximately 90\\% of a single orally administered dose is eliminated in feces and 8\\% in urine. C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents
5b-Cholestane-3a,7a,12a,25,26-pentol
DG(18:1(11Z)/18:1(11Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:1(11Z)/18:1(11Z)/0:0), in particular, consists of two chains of vaccenic acid at the C-1 and C-2 positions. The vaccenic acid moieties are derived from butter fat and animal fat. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. 5b-Cholestane-3a,7a,12a,25,26-pentol is a bile alcohol. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10\\% of total bile acids. Large amounts of bile alcohols have been found to be excreted into the bile and urine in patients with cerebrotendinous xanthomatosis (CTX), a rare inherited lipid storage disease. (PMID: 11718684).
5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol
5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol, also known as 5β-cholestan-3α,7α,12α,24(S),27-pentol, is classified as a pentahydroxy bile acids, alcohol or a Pentahydroxy bile acids, alcohol derivative. Pentahydroxy bile acids, alcohols are bile acids, alcohols or derivatives bearing five hydroxyl groups. 5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol is considered to be practically insoluble (in water) and relatively neutral
Tyromycic acid
Tyromycic acid is found in mushrooms. Tyromycic acid is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Tyromycic acid is found in mushrooms.
5b-Cholestane-3a,7a,12a,24,25-pentol
5b-Cholestane-3a,7a,12a,24,25-pentol has been found excreted in the urine from a patient with sitosterolemia as glycine- and taurine-conjugated bile acids (PMID 7896564) [HMDB] 5b-Cholestane-3a,7a,12a,24,25-pentol has been found excreted in the urine from a patient with sitosterolemia as glycine- and taurine-conjugated bile acids (PMID 7896564).
3-Oxo-12,18-ursadien-28-oic acid
3-Oxo-12,18-ursadien-28-oic acid is found in pomes. 3-Oxo-12,18-ursadien-28-oic acid is a constituent Pyrus communis (pear). Constituent Pyrus communis (pear). 3-Oxo-18-dehydroursolic acid is found in pomes.
5b-Cholestane-3a,7a,12a,23S,25-pentol
5b-Cholestane-3a,7a,12a,23S,25-pentol is a bile alcohol found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 3700361) [HMDB] 5b-Cholestane-3a,7a,12a,23S,25-pentol is a bile alcohol found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 3700361).
5b-Cholestane-3a,7a,12a,23R,25-pentol
5b-Cholestane-3a,7a,12a,23R,25-pentol is a bile alcohol present in the urine of patients with cerebrotendinous xanthomatosis, but not in feces. A possible explanation for the urinary cholestanepentols is that the major serum bile alcohol, 5b-cholestane-3a,7a,12a,25-tetrol, might be hydroxylated at C-23 to form (23)-5b-cholestane-3a,7a,12a,23,25-pentols in the kidneys, an hypothesis supported by the fact that in our patient (23R)-5b-cholestane-3a,7a,12a,23,25-pentol was detected only in urine but were virtually absent in bile. (PMID 3700361). Widespread in plant oils and as glycerides in seed oilsand is also present in apple, apricot, banana, morello cherry, citrus fruits, cheese, butter, white wine, Japanese whiskey, peated malt, wort and scallops. It is used as a defoamer, lubricant and citrus fruit coating. Salts (Na, K, Mg, Ca, Al) used as binders, emulsifiers and anticaking agents in food manuf. Decanoic acid is found in many foods, some of which are radish (variety), meatball, phyllo dough, and american shad.
5a-Cholestane-3a,7a,12a,23,25-pentol
5a-Cholestane-3a,7a,12a,23,25-pentol is a bile acid found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 1805458) [HMDB] 5a-Cholestane-3a,7a,12a,23,25-pentol is a bile acid found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 1805458).
Cholestane-3,7,12,24,25-pentol
Cholestane-3,7,12,24,25-pentol is the major bile alcohol identified in urine from healthy humans, both in children and adults. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10\\% of total bile acids. The excretion of glucuronidated bile alcohols in urine is suggested to reflect an alternative metabolism of intermediates in the normal biosynthesis of bile acids. Patients with the rare inherited sterol storage disease, cerebrotendinous xanthomatosis, accumulation bile alcohols in bile and feces.(PMID: 6726087, 6548247, 11718684) [HMDB] Cholestane-3,7,12,24,25-pentol is the major bile alcohol identified in urine from healthy humans, both in children and adults. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10\\% of total bile acids. The excretion of glucuronidated bile alcohols in urine is suggested to reflect an alternative metabolism of intermediates in the normal biosynthesis of bile acids. Patients with the rare inherited sterol storage disease, cerebrotendinous xanthomatosis, accumulation bile alcohols in bile and feces.(PMID: 6726087, 6548247, 11718684).
1-nonadecanoyl-glycero-3-phosphate
1-nonadecanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-nonadecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule
5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol
5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol, also known as 5β-cholestane-3α,7α,12α,23,25-pentol, is classified as a pentahydroxy bile acids, alcohol or a Pentahydroxy bile acids, alcohol derivative. Pentahydroxy bile acids, alcohols are bile acids, alcohols or derivatives bearing five hydroxyl groups. 5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol is considered to be practically insoluble (in water) and relatively neutral. 5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol is a bile acid lipid molecule
LysoPA(19:0/0:0)
LysoPA(19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(19:0/0:0), in particular, consists of one chain of nonadecylic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(i-19:0/0:0)
LysoPA(i-19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-19:0/0:0), in particular, consists of one chain of isononadecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
24,24-Difluoro-1alpha,25-dihydroxyvitamin D3
C27H42F2O3 (452.31018459999996)
5alpha-Cyprinol
Parenabol
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Tribendimidine
Tribendimidine is an orally active, broad-spectrum anthelmintic agent, with particularly high activity against A. lumbricoides and N. americanus. Tribendimidine is also an L-type nicotinic acetylcholine receptor (nAChR) agonist[1][2][3].
1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea
(8S,9S,10R,13R,14S,17R)-5,6-Dihydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)
DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)
DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)
DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))
DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Kulactone
16,21-Epoxylanosta-7,24-diene-3,21-dione is a natural product found in Melia with data available.
Lucialdehyde B
A tetracyclic triterpenoid that is lanosta-8,24-dien-26-al substituted by oxo groups at positions 3 and 7. Isolated from Ganoderma lucidum and Ganoderma pfeifferi, it exhibits antiviral and cytotoxic activities.
Tyromycic acid
7-O-Demethylisocephaeline
A pyridoisoquinoline consisting of (1beta)-emetan substituted by hydroxy groups at positions 6 and 7 and methoxy groups at positions 10 and 11. It is isolated from Psychotria klugii and exhibits antileishmanial activity.
(20R,24S)-5alpha-cholesta-3beta,6alpha,8,15alpha,24-pentaol|(24S)-5alpha-cholestane-3beta,6alpha,8,15alpha,24-pentol
Wilforlide B
Wilforlide B is a natural product found in Tripterygium regelii and Tripterygium wilfordii with data available.
methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate
2alpha,3beta-dihydroxy-28-norurs-12,17,19(20),21(22)-tetraen-23-oic acid|2alpha,3beta-dihydroxy-28-norursa-12,17,19(20),21-tetraen-23-oic acid
(1S,4R,5R)-3-hydroxymethyl-4,5-dimethoxycyclohex-2-enyl (3E)-octadec-3-enoate
3-Oxo-ursadien-(12.19)-saeure-(28)|Sanguisorbigenon|sanguisorbigenone|Tomentosonsaeure
18-dihydrocinnamoyloxy-labda-7,13E-dien-15-oic acid
19-(p-hydroxyhydrocinnamoyloxy)-ent-kauran-17-al|19--ent-kauran-17-al
(17R,20R)-cycloart-24-en-3,16,23-trione|(9beta)-9,19-cyclolanost-24-ene-3,16,23-trione|5alpha-cycloart-24-ene-3,16,23-trione|gummiferartane-6
1,8,15,22-Tetraaza-2,7,16,21-cyclooctacosanetetrone
(3beta, 5alpha, 6beta, 15alpha, 25S)-Cholestane-3, 5, 6, 15, 25-pentol
14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid
(20xi)-3-oxolanosta-7,9(11),24-trien-21-oic acid|3-oxolanosta-7,9(11),24-trien-21-oic acid|dehydrotrametenonic acid
(2,3-dihydro-3-methylenebenzo[b]oxepin-7-yl)methyl oleate
1,8,15,22-Tetraazacyclooctacosane-2,9,16,23-tetrone
13-O-alpha-rhamnopyranosyl-(+)-3beta-hydroxymanool
(4S,5S,7R,10S)-Eudesm-11-en-4-ol 2-O-((2S) 2-methylbutyryl)-beta-D-fucopyranoside|(4S,5S,7R,10S)-Eudesm-11-en-4-ol 2-O-<(2S) 2-methylbutyryl>-beta-D-fucopyranoside
(1beta)-25(9-8)-Abeo-3-oxo-4(23)-friedelen-24,1-olide
O-3-isovaleroyl alpha-bisabolol beta-D-fucopyranoside
(2Z,6R)-2-methyl-6-[(12beta)-4,4,10,12,14-pentamethyl-3-oxogona-8,13(17)-dien-17-yl]hept-2-enoic acid|kadindutic acid
18-methylmalonyl-7alpha-hydroxy-methyltrineracetal
3alpha,7alpha,12alpha,23-Tetrahydroxy-cholansaeure-ethylester
(23R)-3-oxo-5alpha,9beta-lanosta-7,24-dien-26,23-olide
8|A-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate
26-hydroxy-5alpha-lanosta-7,9(11),24-triene-3,22-dione
lettowinone|methyl [3-(3,7-dimethylocta.2,6-dienyl)-6-methyl-5-(3-methylbut-2-enyl)-1,4-dioxo-1,5,8,8a-tetrahydro-4H-naphthalen-4a-yl]acetate
6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide
2.3-dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-oic acid-(29)|2.3-Dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-saeure-(29)|Dihydrocelastrol
13S-labda-8(17),14-diene-13-(cis-hydroxycinnamoxy)-19-ol
6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F
3-oxo-D:C-friedo-olena-7,9(11)-dien-29-oic acid|3-oxo-D:C-friedooleana-7,9(11)-dien-29-oic acid
17-hydroxy-19-(p-hydroxyhydrocinnamoyloxy)-iso-kaurene|17-hydroxy-19--iso-kaurene
Benzamide, N-(20-amino-4,8,12,17-tetraazaeicos-1-yl)-2,5-dihydroxy-
Triptohypol C
Triptohypol C is a pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. It has a role as a plant metabolite and an apoptosis inducer. It is a pentacyclic triterpenoid, a monocarboxylic acid and a member of benzenediols. Dihydrocelastrol is a natural product found in Tripterygium hypoglaucum and Tripterygium wilfordii with data available. A pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. Triptohypol C, a Tripterin (HY-13067) derivative, is a potent Nur77-targeting anti-inflammatory agent with an Kd value of 0.87 μM. Triptohypol C inhibits inflammatory response by promoting the interactions of Nur77 with TRAF2 and p62/SQSTM1[1].
Repaglinide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 2189 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3349
C30H44O3_(22E,24E)-3-Oxo-9,19-cyclolanosta-22,24-dien-26-oic acid
(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R,5S)-5,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5S,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5R,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
Ala His Ile Ile
Ala His Ile Leu
Ala His Leu Ile
Ala His Leu Leu
Ala Ile His Ile
Ala Ile His Leu
Ala Ile Ile His
Ala Ile Leu His
Ala Leu His Ile
Ala Leu His Leu
Ala Leu Ile His
Ala Leu Leu His
His Ala Ile Ile
His Ala Ile Leu
His Ala Leu Ile
His Ala Leu Leu
His Ile Ala Ile
His Ile Ala Leu
His Ile Ile Ala
His Ile Leu Ala
His Leu Ala Ile
His Leu Ala Leu
His Leu Ile Ala
His Leu Leu Ala
His Val Val Val
Ile Ala His Ile
Ile Ala His Leu
Ile Ala Ile His
Ile Ala Leu His
Ile His Ala Ile
Ile His Ala Leu
Ile His Ile Ala
Ile His Leu Ala
Ile Ile Ala His
Ile Ile His Ala
Ile Leu Ala His
Ile Leu His Ala
Leu Ala His Ile
Leu Ala His Leu
Leu Ala Ile His
Leu Ala Leu His
Leu His Ala Ile
Leu His Ala Leu
Leu His Ile Ala
Leu His Leu Ala
Leu Ile Ala His
Leu Ile His Ala
Leu Leu Ala His
Leu Leu His Ala
Val His Val Val
Val Val His Val
Val Val Val His
4,4-difluoro-1α,25-dihydroxyvitamin D3 / 4,4-difluoro-1α,25-dihydroxycholecalciferol
C27H42F2O3 (452.31018459999996)
(5Z,7E)-(1S,3S)-4,4-difluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
C27H42F2O3 (452.31018459999996)
23,23-difluoro-1α,25-dihydroxyvitamin D3 / 23,23-difluoro-1α,25-dihydroxycholecalciferol
C27H42F2O3 (452.31018459999996)
24,24-difluoro-1α,25-dihydroxyvitamin D3 / 24,24-difluoro-1α,25-dihydroxycholecalciferol
C27H42F2O3 (452.31018459999996)
(5Z,7E,17E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol
(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol
(5Z,7E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),20-cholestatetraen-22-yne-1,3,25-triol
(5Z,7E,22E,24E,24bE)-(1S,3R)-24a,24b,24c-trihomo-9,10-seco-5,7,10(19),22,24,24b-cholestahexaene-1,3,25-triol
VD 2728
VD 2736
Cholestane-3,7,12,24,25-pentol
5beta-Cholestane-2beta,3alpha,7alpha,12alpha,26-pentol
5alpha-Cholestane-3beta,7alpha,12alpha,25,26-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,25,26-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,24,26-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,22,25-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,23,25-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,24,25-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,26,27-pentol
5alpha-Cholestane-3alpha,7alpha,12alpha,23,25-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,22,26-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,23,26-pentol
3-Oxo-12,18-ursadien-28-oic acid
4,4-difluoro-1alpha,25-dihydroxyvitamin D3
C27H42O3F2 (452.31018459999996)
23,23-difluoro-1alpha,25-dihydroxyvitamin D3
C27H42O3F2 (452.31018459999996)
24,24-difluoro-1alpha,25-dihydroxyvitamin D3
C27H42O3F2 (452.31018459999996)
(17E)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a-homovitamin D3
(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a-homovitamin D3
1alpha,25-dihydroxy-26,27-dimethyl-20,21,22,22,23,23-hexadehydro-24a-homovitamin D3
(22E,24E,24bE)-1alpha,25-dihydroxy-22,23,24,24a,24b,24c-hexadehydro-24a,24b,24c-trihomovitamin D3
POLY(LAURYL METHACRYLATE-CO-ETHYLENE GLYCOL DIMETHACRYLATE)
8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnaMate
1-Propanol, 2-methoxy-3-[(9Z)-9-octadecenyloxy]-, dihydrogen phosphorothioate, (2R)
C22H45O5PS (452.27251700000005)
1-hexadecyl-3-methylimidazolium hexafluorophosphate
N-(2-ethoxyphenyl)-N-(4-isododecylphenyl)oxamide
C28H40N2O3 (452.30387700000006)
Boldenone undecylenate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Etripamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea
YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A[1][2].
(24S)-5beta-cholestane-3alpha,7alpha,12alpha,24,26-pentol
5beta-Cholestane-3alpha,7alpha,12alpha,24,26-pentol with S-configuration at C-24.
Butropium
C28H38NO4+ (452.28006880000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
2-Ethoxy-4-[2-[[3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
23,23-difluoro-1alpha,25-dihydroxyvitamin D3/23,23-difluoro-1alpha,25-dihydroxycholecalciferol
C27H42F2O3 (452.31018459999996)
N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)
C21H43NO7P- (452.27769980000005)
[(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-bis(azaniumyl)-3-[[(2S,3R)-3-azaniumyl-6-(azaniumylmethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-3,5-dihydroxy-5-methyloxan-4-yl]-methylazanium
C19H42N5O7+5 (452.30840820000003)
(8S,9S,10R,13R,14S,17R)-5,6-Dihydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
(5Z)-5-[(2E)-2-[1-(5,5-difluoro-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
C27H42F2O3 (452.31018459999996)
[3-carboxy-2-[(10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoyl]oxypropyl]-trimethylazanium
C25H42NO6+ (452.30119720000005)
[3-carboxy-2-[(10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoyl]oxypropyl]-trimethylazanium
C25H42NO6+ (452.30119720000005)
[3-Carboxy-2-[11-(3-methyl-5-propylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[10-(3,4-dimethyl-5-propylfuran-2-yl)decanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[11-(5-ethyl-3,4-dimethylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[7-(5-hexyl-3,4-dimethylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[8-(3,4-dimethyl-5-pentylfuran-2-yl)octanoyloxy]propyl]-trimethylazanium
[2-[9-(5-Butyl-3,4-dimethylfuran-2-yl)nonanoyloxy]-3-carboxypropyl]-trimethylazanium
[3-Carboxy-2-[9-(3-methyl-5-pentylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium
8alpha-Hydroxylabda-13(16),14-dien-19-yl-cis-4-hydroxycinnamate
A natural product found in Metasequoia glyptostroboides.
Ala-Leu-Leu-His
A tetrapeptide composed of L-alanine, two L-leucine units, and an L-histidine joined in sequence.
epiandrosterone 3-beta-D-glucoside
A sterol 3-beta-D-glucoside that has epiandrosterone as the sterol component.
(2E,4E)-2-methyl-6-(7,7,12,16-tetramethyl-6-oxo-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl)hepta-2,4-dienoic acid
5alpha-cholestan-3beta,6alpha,8beta,15alpha,24S-triol
4-(dimethylamino)-N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbutanamide
C22H40N6O4 (452.31108800000004)
4-(dimethylamino)-N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide
C22H40N6O4 (452.31108800000004)
4-(dimethylamino)-N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide
C22H40N6O4 (452.31108800000004)
4-(dimethylamino)-N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide
C22H40N6O4 (452.31108800000004)
(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R,5S)-5,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol
2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO7P+ (452.27769980000005)
2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetradec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetradec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
[(2S)-2-hydroxy-3-[(3R,7R,11R)-3,7,11,15-tetramethylhexadecoxy]propyl] dihydrogen phosphate
C23H49O6P (452.32665840000004)
(1-hexanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
[2-(Heptanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetamido-3-hydroxytetradecyl) 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[3-Hydroxy-2-(octanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-acetyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C21H43NO7P+ (452.27769980000005)
2-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
(25S)-5alpha-cholestan-3beta,6beta,15alpha,16beta,26-pentol
(5Z,7E,16Z,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestahexaene-1,3,25-triol
(5Z,7E,16Z,22E,24E)-(1S,3R,20S)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestahexaene-1,3,25-triol
lysophosphatidylethanolamine zwitterion 16:0
C21H43NO7P (452.27769980000005)
A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.
BisMeLPA(17:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
DG(24:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved